The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection
Open accessAbstract
Interleukin-1 (IL-1) receptor signaling is necessary for control of Mycobacterium tuberculosis (Mtb) infection, yet the role of its two ligands, IL-1α and IL-1β, and their regulation in vivo are poorly understood. Here, we showed that both IL-1α and IL-1β are critically required for host resistance and identified two multifunctional inflammatory monocyte-macrophage and DC populations that coexpressed both IL-1 species at the single-cell level in lungs of Mtb-infected mice. Moreover, we demonstrated that interferons (IFNs) played important roles in regulating IL-1 production by these cells in vivo. Type I interferons inhibited IL-1 production by both subsets whereas CD4(+) T cell-derived IFN-γ selectively suppressed monocyte-macrophages. These data provide a cellular basis for both the anti-inflammatory effects of IFNs and probacterial functions of type I IFNs during Mtb infection and reveal differential regulation of IL-1 production by distinct cell populations as an additional layer of complexity in the activity of IL-1 in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-1β is massively induced upon infection of macrophages with M. tuberculosis, and it appears to play important roles in anti-mycobacterial immune defenses because knockout mice are more susceptible to this infection (98)”
From Macrophage defense mechanisms against intracellular bacteria (2015) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection.
Serbina, N., Salazar-Mather, T. P., Biron, C., Kuziel, W., & Pamer, E. (2003) · Immunity · doi:10.1016/s1074-7613(03)00171-7 · Cited by 1,293
Flynn, J., & Chan, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 1,144
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
Guarda, G., Braun, M., Staehli, F., Tardivel, A., Mattmann, C., Förster, I., Farlik, M., Decker, T., Pasquier, R. D., Romero, P. J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.006 · Cited by 924
Type I interferon: friend or foe?
Trinchieri, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101664 · Cited by 838
North, R. J., & Jung, Y. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
Cheong, C., de Matos, I. G., Choi, J., Dandamudi, D. B., Shrestha, E., Longhi, M. P., Jeffrey, K. L., Anthony, R. M., Kluger, C., Nchinda, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.039 · Cited by 640
Manca, C., Tsenova, L., Bergtold, A., Freeman, S. L., Tovey, M. G., Musser, J. M., Barry, C. E., Freedman, V. H., & Kaplan, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091096998 · Cited by 590
Cited by
Sorted by citations
Inflammasomes: mechanism of assembly, regulation and signalling
Broz, P., & Dixit, V. M. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.58 · Cited by 3,500
Regulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2013) · Nature reviews. Immunology · doi:10.1038/nri3581 · Cited by 3,442
Type I interferons in infectious disease
McNab, F., Mayer-Barber, K., Sher, A., Wack, A., & O'Garra, A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3787 · Cited by 2,780
Self-citationThe Immune Response in Tuberculosis
O’Garra, A., Redford, P. S., McNab, F. W., Bloom, C. I., Wilkinson, R. J., & Berry, M. P. R. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095939 · Cited by 1,400
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,141
Macrophage defense mechanisms against intracellular bacteria
Weiss, G., & Schaible, U. E. (2015) · Immunological Reviews · doi:10.1111/imr.12266 · Cited by 989
Regulation of inflammasome signaling
Rathinam, V. A. K., Vanaja, S. K., & Fitzgerald, K. A. (2012) · Nature Immunology · doi:10.1038/ni.2237 · Cited by 960
Intravascular staining for discrimination of vascular and tissue leukocytes
Anderson, K. G., Mayer-Barber, K., Sung, H., Beura, L., James, B. R., Taylor, J. J., Qunaj, L., Griffith, T. S., Vezys, V., Barber, D. L., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.005 · Cited by 812
Self-citationHost-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 757
Self-citationTBK-1 Promotes Autophagy-Mediated Antimicrobial Defense by Controlling Autophagosome Maturation
Pilli, M., Arko-Mensah, J., Ponpuak, M., Roberts, E., Master, S., Mandell, M. A., Dupont, N., Ornatowski, W., Jiang, S., Bradfute, S. B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.04.015 · Cited by 655
Watson, R. O., Bell, S. L., MacDuff, D. A., Kimmey, J. M., Diner, E. J., Olivas, J., Vance, R. E., Stallings, C. L., Virgin, H. W., & Cox, J. S. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.004 · Cited by 645
The immunological life cycle of tuberculosis
Ernst, J. (2012) · Nature reviews. Immunology · doi:10.1038/nri3259 · Cited by 598
Mishra, B. B., Rathinam, V. A. K., Martens, G. W., Martinot, A. J., Kornfeld, H., Fitzgerald, K. A., & Sassetti, C. M. (2013) · Nature Immunology · doi:10.1038/ni.2474 · Cited by 571
A major role for ferroptosis in Mycobacterium tuberculosis –induced cell death and tissue necrosis
Amaral, E. P., Costa, D. L., Namasivayam, S., Riteau, N., Kamenyeva, O., Mittereder, L., Mayer-Barber, K. D., Andrade, B. B., & Sher, A. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181776 · Cited by 464
Self-citationAutophagy protects against active tuberculosis by suppressing bacterial burden and inflammation
Castillo, E. F., Dekonenko, A., Arko‐Mensah, J., Mandell, M. A., Dupont, N., Jiang, S., Delgado-Vargas, M., Timmins, G. S., Bhattacharya, D., Yang, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210500109 · Cited by 462
Wassermann, R., Gulen, M. F., Sala, C., Perin, S. G., Lou, Y., Rybniker, J., Schmid-Burgk, J. L., Schmidt, T., Hornung, V., Cole, S. T., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.05.003 · Cited by 401
Cytokines and Chemokines inMycobacterium tuberculosisInfection
Domingo-Gonzalez, R., Prince, O. A., Cooper, A. M., & Khader, S. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tbtb2-0018-2016 · Cited by 434
T cells and adaptive immunity to Mycobacterium tuberculosis in humans
Jasenosky, L. D., Scriba, T. J., Hanekom, W. A., & Goldfeld, A. E. (2015) · Immunological Reviews · doi:10.1111/imr.12274 · Cited by 370
Sakai, S., Kauffman, K. D., Sallin, M. A., Sharpe, A. H., Young, H. A., Ganusov, V. V., & Barber, D. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005667 · Cited by 349
Self-citationSTING pathway agonism as a cancer therapeutic
Flood, B. A., Higgs, E. F., Li, S., Luke, J. J., & Gajewski, T. F. (2019) · Immunological Reviews · doi:10.1111/imr.12765 · Cited by 340
Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis
Cavalcanti, Y. V. N., de Castro, M. C. A. B., Neves, J. K. D. A. L., Ferraz, J. C., & Pereira, V. R. A. (2012) · Pulmonary Medicine · doi:10.1155/2012/745483 · Cited by 341
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 337
Inflammatory dendritic cells in mice and humans
Segura, É., & Amigorena, S. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.06.001 · Cited by 301
Type I interferons in tuberculosis: Foe and occasionally friend
Moreira-Teixeira, L., Mayer-Barber, K. D., Sher, A., & O’Garra, A. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180325 · Cited by 284
Self-citationWang, Y., Ning, X., Gao, P., Wu, S., Sha, M., Lv, M., Zhou, X., Gao, J., Fang, R., Meng, G., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.011 · Cited by 279
Guilliams, M., Lambrecht, B. N., & Hammad, H. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.14 · Cited by 276
The balance between protective and pathogenic immune responses in the TB-infected lung
Orme, I. M., Robinson, R., & Cooper, A. M. (2014) · Nature Immunology · doi:10.1038/ni.3048 · Cited by 295
Tyrosine Phosphatase PTPN22: Multifunctional Regulator of Immune Signaling, Development, and Disease
Bottini, N., & Peterson, E. J. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120249 · Cited by 240
Moreira-Teixeira, L., Stimpson, P., Stavropoulos, E., Hadebe, S., Chakravarty, P., Ιωάννου, Μ., Aramburu, I. V., Herbert, E., Priestnall, S. L., Suárez‐Bonnet, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19412-6 · Cited by 235
Dorhoi, A., Yeremeev, V., Nouailles, G., Weiner, J. M., Jörg, S., Heinemann, E., Oberbeck‐Müller, D., Knaul, J. K., Vogelzang, A., Reece, S. T., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344219 · Cited by 239
Jayaraman, P., Sada‐Ovalle, I., Nishimura, T., Anderson, A. C., Kuchroo, V. K., Remold, H. G., & Behar, S. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202688 · Cited by 217
Mayer-Barber, K. D., & Yan, B. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.25 · Cited by 210
Self-citationThe Innate Immune Response to Mycobacterium tuberculosis Infection
Ravesloot-Chávez, M. M., Dis, E. S. V., & Stanley, S. A. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-010426 · Cited by 213
Post-translational regulation of inflammasomes
Yang, J., Liu, Z., & Xiao, T. S. (2016) · Cellular and Molecular Immunology · doi:10.1038/cmi.2016.29 · Cited by 211
Critical role of AIM2 in Mycobacterium tuberculosis infection
Saiga, H., Kitada, S., Shimada, Y., Kamiyama, N., Okuyama, M., Makino, M., Yamamoto, M., & Takeda, K. (2012) · International Immunology · doi:10.1093/intimm/dxs062 · Cited by 202
McNab, F. W., Ewbank, J., Howes, A., Moreira-Teixeira, L., Մարտիրոսյան, Ա., Ghilardi, N., Saraiva, M., & O’Garra, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401088 · Cited by 211
Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections
Davidson, S., Maini, M. K., & Wack, A. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0227 · Cited by 201
Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra
Ji, D. X., Yamashiro, L. H., Chen, K. J., Mukaida, N., Kramnik, I., Darwin, K. H., & Vance, R. E. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0578-3 · Cited by 183
Singh, T. P., Zhang, H. H., Borek, I., Wolf, P., Hedrick, M. N., SINGH, S. P., Kelsall, B. L., Clausen, B. E., & Farber, J. M. (2016) · Nature Communications · doi:10.1038/ncomms13581 · Cited by 181
Tuberculosis and the art of macrophage manipulation
Upadhyay, S., Mittal, E., & Philips, J. A. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty037 · Cited by 186
The Regulation of IL-10 Expression
Gabryšová, L., Howes, A., Saraiva, M., & O’Garra, A. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-43492-5_8 · Cited by 181
Ali, S., Mann‐Nüttel, R., Schulze, A., Richter, L., Alferink, J., & Scheu, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00778 · Cited by 176
Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis InfectionPreprint
Mayer-Barber, K. D., & Barber, D. L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018424 · Cited by 179
Self-citationCaspase-11 Activation in Response to Bacterial Secretion Systems that Access the Host Cytosol
Casson, C. N., Copenhaver, A. M., Zwack, E. E., Nguyen, H. T., Strowig, T., Javdan, B., Bradley, W. P., Fung, T. C., Flavell, R. A., Brodsky, I. E., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003400 · Cited by 181
Dynamic Roles of Type I and Type II IFNs in Early Infection with Mycobacterium tuberculosis
Desvignes, L., Wolf, A. J., & Ernst, J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200255 · Cited by 172
Gong, W., & Wu, X. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.745592 · Cited by 176
Beyond macrophages: the diversity of mononuclear cells in tuberculosis
Srivastava, S., Ernst, J., & Desvignes, L. (2014) · Immunological Reviews · doi:10.1111/imr.12217 · Cited by 174
Pitt, J. M., Stavropoulos, E., Redford, P. S., Beebe, A. M., Bancroft, G. J., Young, D. B., & O’Garra, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201061 · Cited by 172
Regulation of Interleukin-10 Expression
Rutz, S., & Ouyang, W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_5 · Cited by 172
Tumor necrosis factor alpha in mycobacterial infection
Dorhoi, A., & Kaufmann, S. H. E. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.003 · Cited by 171
The human immune response to tuberculosis and its treatment: a view from the blood
Cliff, J. M., Kaufmann, S. H. E., McShane, H., van Helden, P. D., & O’Garra, A. (2015) · Immunological Reviews · doi:10.1111/imr.12269 · Cited by 161
Immune cell interactions in tuberculosis
Flynn, J. L., & Chan, J. (2022) · Cell · doi:10.1016/j.cell.2022.10.025 · Cited by 161
Cytokine and lipid mediator networks in tuberculosis
Mayer-Barber, K. D., & Sher, A. (2015) · Immunological Reviews · doi:10.1111/imr.12249 · Cited by 158
Self-citationHow Inflammasomes Inform Adaptive Immunity
Evavold, C. L., & Kagan, J. C. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.019 · Cited by 155
Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis
Kotov, D. I., Lee, O. V., Fattinger, S. A., Langner, C. A., Guillen, J. V., Peters, J. M., Moon, A., Burd, E. M., Witt, K. C., Stetson, D. B., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.002 · Cited by 146
Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis
Dorhoi, A., & Kaufmann, S. H. E. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0531-3 · Cited by 156
Redford, P. S., Mayer-Barber, K. D., McNab, F. W., Stavropoulos, E., Wack, A., Sher, A., & O’Garra, A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit424 · Cited by 136
Self-citationCharmoy, M., Hurrell, B. P., Romano, A., Lee, S. H., Ribeiro-Gomes, F. L., Riteau, N., Mayer-Barber, K. D., Tacchini‐Cottier, F., & Sacks, D. L. (2015) · European Journal of Immunology · doi:10.1002/eji.201546015 · Cited by 135
Self-citationPlumlee, C. R., Duffy, F. J., Gern, B. H., Delahaye, J. L., Cohen, S. B., Stoltzfus, C. R., Rustad, T. R., Hansen, S. G., Axthelm, M. K., Picker, L. J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.10.003 · Cited by 141
Type I interferon decreases macrophage energy metabolism during mycobacterial infection
Olson, G. S., Murray, T. A., Jahn, A. N., Mai, D., Diercks, A. H., Gold, E. S., & Aderem, A. A. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109195 · Cited by 131
Mechanisms of M. tuberculosis Immune Evasion as Challenges to TB Vaccine Design
Ernst, J. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.004 · Cited by 137
Caffrey, A. K., Lehmann, M. M., Zickovich, J. M., Espinosa, V., Shepardson, K. M., Watschke, C. P., Hilmer, K. M., Thammahong, A., Barker, B. M., Rivera, A., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004625 · Cited by 132
Inflammation in tuberculosis: interactions, imbalances and interventions
Kaufmann, S. H. E., & Dorhoi, A. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.05.005 · Cited by 138
Hossain, M. M., & Norazmi, M. N. (2013) · BioMed Research International · doi:10.1155/2013/179174 · Cited by 146
IL-1α Signaling Initiates the Inflammatory Response to Virulent Legionella pneumophila In Vivo
Barry, K. C., Fontana, M. F., Portman, J. L., Dugan, A. S., & Vance, R. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300100 · Cited by 128
Macrophage immunoregulatory pathways in tuberculosis
Rajaram, M. V. S., Ni, B., Dodd, C. E., & Schlesinger, L. S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.010 · Cited by 131
Shah, S., Bohsali, A., Ahlbrand, S. E., Srinivasan, L., Rathinam, V. A. K., Vogel, S. N., Fitzgerald, K. A., Sutterwala, F. S., & Briken, V. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301331 · Cited by 123
Host-Directed Therapies for Tuberculosis: Figure 1.Preprint
Tobin, D. M. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021196 · Cited by 123
Type I interferon signaling mediates Mycobacterium tuberculosis –induced macrophage death
Zhang, L., Jiang, X., Pfau, D. J., Ling, Y., & Nathan, C. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200887 · Cited by 115
Intracellular Bacillary Burden Reflects a Burst Size for Mycobacterium tuberculosis In Vivo
Repasy, T., Lee, J., Marino, S., Martínez, N., Kirschner, D. E., Hendricks, G. M., Baker, S. P., Wilson, A. A., Kotton, D. N., & Kornfeld, H. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003190 · Cited by 123
Kumar, N. P., Sridhar, R., Banurekha, V. V., Jawahar, M. S., Fay, M. P., Nutman, T. B., & Babu, S. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201305-112oc · Cited by 119
T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection
Moreira-Teixeira, L., Redford, P. S., Stavropoulos, E., Ghilardi, N., Maynard, C. L., Weaver, C. T., do Rosário, A. P. F., Wu, X., Langhorne, J., & O’Garra, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601340 · Cited by 122
Amaral, E. P., Riteau, N., Moayeri, M., Maier, N. K., Mayer-Barber, K. D., Pereira, R. M., Lage, S. L., Kübler, A., Bishai, W. R., Lima, M. R. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01427 · Cited by 118
Self-citationAmaral, E. P., Conceição, E. L., Costa, D. L., Rocha, M. S., Marinho, J. M., Cordeiro‐Santos, M., Lima, M. R. D., Barbosa, T., Sher, A., & Andrade, B. B. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0872-7 · Cited by 122
Self-citationType I interferons in bacterial infections: A balancing act
Kovarik, P., Castiglia, V., Ivin, M., & Ebner, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00652 · Cited by 117
Donovan, M. L., Schultz, T. E., Duke, T. J., & Blumenthal, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01633 · Cited by 117
Fejér, G., Wegner, M., Győry, I., Cohen, I., Engelhard, P., Voronov, E., Manke, T., Ruzsics, Z., Dölken, L., da Costa, O. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302877110 · Cited by 118
Host defense mechanisms against Mycobacterium tuberculosis
Chai, Q., Lü, Z., & Liu, C. H. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03353-5 · Cited by 125
Towards efficient immunotherapy for bacterial infection
McCulloch, T. R., Wells, T. J., & Souza-Fonseca-Guimarães, F. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.05.005 · Cited by 116
Oh, J. Y., Ko, J. H., Lee, H. J., Yu, J. M., Choi, H., Kim, M. K., Wee, W. R., & Prockop, D. J. (2014) · Stem Cells · doi:10.1002/stem.1608 · Cited by 125
Investigating the Causes for Decreased Levels of Glutathione in Individuals with Type II Diabetes
Lagman, M., Ly, J., Saing, T., Singh, M., Tudela, E. V., Morris, D., Chi, P.-T., Ochoa, C., Sathananthan, A., & Venketaraman, V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118436 · Cited by 108
Autophagy as an immune effector against tuberculosis
Bradfute, S. B., Castillo, E. F., Arko‐Mensah, J., Chauhan, S., Jiang, S., Mandell, M. A., & Deretic, V. P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.05.003 · Cited by 104
de, M. M., Kumar, R., Rivera, F. D. L., Amante, F. H., Sheel, M., Faleiro, R. J., Bunn, P. T., Best, S. E., Beattie, L., Ng, S. S., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.015 · Cited by 102
GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection
Amaral, E. P., Foreman, T. W., Namasivayam, S., Hilligan, K. L., Kauffman, K. D., Bomfim, C. C. B., Costa, D. L., Barreto‐Duarte, B., Rocha, C. A. G., Santana, M. F., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220504 · Cited by 106
Self-citationChronic Bystander Infections and Immunity to Unrelated Antigens
Stelekati, E., & Wherry, E. J. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.10.001 · Cited by 103
Autophagy in TuberculosisPreprint
Deretic, V. P. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018481 · Cited by 100
Malireddi, R. K. S., & Kanneganti, T. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00077 · Cited by 101
Paolo, N. C. D., Shafiani, S., Day, T., Papayannopoulou, T., Russell, D. W., Iwakura, Y., Sherman, D. R., Urdahl, K. B., & Shayakhmetov, D. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.11.016 · Cited by 96
Moreira-Teixeira, L., Sousa, J., McNab, F. W., Torrado, E., Cardoso, F., Machado, H., Castro, F., Cardoso, V., Gaifem, J., Wu, X., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600584 · Cited by 99
Castiglia, V., Piersigilli, A., Ebner, F., Janos, M., Goldmann, O., Damböck, U., Kröger, A., Weiss, S., Knapp, S., Jamieson, A. M., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.003 · Cited by 96
Innate immunity and tolerance toward mitochondria
Rongvaux, A. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.10.007 · Cited by 115
Amaral, E. P., Ribeiro, S. C. M., Lanes, V. R., Almeida, F. M., de Andrade, M. R. M., Bomfim, C. C. B., de Salles, É. M., Bortoluci, K. R., Coutinho‐Silva, R., Hirata, M. H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004188 · Cited by 99
McNab, F. W., Ewbank, J., Rajsbaum, R., Stavropoulos, E., Մարտիրոսյան, Ա., Redford, P. S., Wu, X., Graham, C. M., Saraiva, M., Tsichlis, P. N., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300146 · Cited by 96
The Interplay Between Systemic Inflammation, Oxidative Stress, and Tissue Remodeling in Tuberculosis
Amaral, E. P., Vinhaes, C. L., Oliveira-de-Souza, D., Nogueira, B. M. F., Akrami, K., & Andrade, B. B. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8124 · Cited by 101
Self-citationSusceptibility to chronic inflammation: an update
Nasef, N. A., Mehta, S. Y., & Ferguson, L. R. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1914-5 · Cited by 103
The role of type I interferons in intestinal infection, homeostasis, and inflammation
Cho, H., & Kelsall, B. L. (2014) · Immunological Reviews · doi:10.1111/imr.12195 · Cited by 94
Inflammasome activation and Th17 responses
Deng, J. P., Yu, X., & Wang, P. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.024 · Cited by 94
Shi, H., Zhang, J., Han, X., Li, H., Xie, M., Sun, Y., Liu, W., Ba, X., & Zeng, X. (2016) · International Journal of Cancer · doi:10.1002/ijc.30538 · Cited by 95
Mycobacterium tuberculosis and the host cell inflammasome: a complex relationship
Briken, V., Ahlbrand, S. E., & Shah, S. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00062 · Cited by 92
Ivin, M., Dumigan, A., Vasconcelos, F., Ebner, F., Borroni, M., Kavirayani, A. M., Przybyszewska, K., Ingram, R. J., Lienenklaus, S., Kalinke, U., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006696 · Cited by 85
Metadata
- Authors
- Mayer-Barber, K. D., Andrade, B. B., Barber, D. L., Hieny, S., Feng, C. G., Caspar, P., Oland, S., Gordon, S., & Sher, A.
- Affiliations
- National Institutes of Health (US)
- University of Oxford (GB)
- Corresponding author
- Mayer-Barber, Katrin D.
- Sher, Alan
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 35
- Issue
- 6
- Pages
- 1023-1034
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC3246221
- OpenAlex
- W2023478821
- Cited by
- 418
- References
- 48
- Citations by year
- 2026: 16 · 2025: 26 · 2024: 25 · 2023: 31 · 2022: 33 · 2021: 18 · 2020: 27 · 2019: 31 · 2018: 23 · 2017: 31 · 2016: 38 · 2015: 37 · 2014: 31 · 2013: 37 · 2012: 14
- FWCI
- 17.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99 AI999999)
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases (Y99 AI999999)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- Mycobacterium tuberculosis infection, interleukin-1 alpha, IL-1β, type I interferon, innate immunity, adaptive immunity, monocytes/macrophages, dendritic cells, host resistance, IL-1 signaling, single-cell analysis
- MeSH terms
- Animals, Antigens, Ly, Dendritic Cells, Humans, Interferons, Lung, Mice, Inbred C57BL, Mycobacterium tuberculosis, Phagocytes, Tuberculosis, Pulmonary, Signal Transduction, CD4-Positive T-Lymphocytes, Mice, Knockout, Myeloid Cells, CD11b Antigen, Mice, Interleukin-1alpha, Interleukin-1beta, Interleukin-12 Subunit p40
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review